印度寄希望于4款新冠疫苗，到明年7月为3亿人接种

Covid-19: India pins hopes on 4 vaccines to inoculate 30 crore by July

印度寄希望于4款新冠疫苗，到明年7月为3亿人接种

u=3964601874,2073001354&fm=26&gp=0.jpg

NEW DELHI: The government is expecting two vaccines against Covid-19 — Oxford-AstraZeneca’s Covishield and Bharat Biotech’s Covaxn — to be available by January and around four vaccines by the end of April, increasing the prospects of adequate supplies to inoculate some 30 crore priority population by July, an official said.

新德里：一名印度官员称，政府预计两种新冠肺炎疫苗——牛津-阿斯利康公司的Covishield和巴拉特生物技术公司的Covaxn——将在明年1月上市，另有约4种疫苗将在4月底上市，从而增加了在明年7月为约3亿重点人群提供充足疫苗供应的希望。

While Covishield, according to a PTI report late on Sunday evening, sought emergency approval, Covaxn is expected to be approved for emergency use by the end of January or early February, if the shots clear scrutiny. The drugs regulator and the government are also examining Pfizer’s application for emergency authorisation and may give the go-ahead but are keen to understand how many shots can be supplied to boost India’s priority vaccination programme.

根据印度报业托拉斯周日晚间的报告，Covishield目前正在寻求紧急批准，如果疫苗注射通过审查，Covaxn疫苗有望在1月底或2月初获准紧急使用。药品监管机构和政府也在审查辉瑞的紧急授权申请，可能会批准，但也想了解他们可以供应多少疫苗，以推动印度的优先接种计划。

Apart from these three, Russia’s Sputnik V is also likely to be rolled out by April. “We are expecting that by April, there will be at least four vaccines in India. So, there should be enough vaccines available to cover the priority group by June-July,” a senior official told TOI.

除了这三种疫苗外，俄罗斯的Sputnik V也可能在4月份推出。一位高级官员告诉印度时报：“我们预计到4月份，印度将至少能获得4种疫苗。因此，到6月至7月，应该有足够的疫苗供重点人群接种。”

Pfizer, which has already got emergency use authorisation in the UK, Bahrain and several other countries for its vaccine candidate, has also applied in India. The National Expert Group on Vaccine Administration (NEGVAC), headed by Niti Aayog member Dr V K Paul, and the subject expert committee (SEC) under the Central Drugs Control Organisation will review the application over the next few days.

辉瑞已经在英国、巴林和其他几个国家获得紧急使用许可，该公司的候选疫苗也已在印度申请紧急使用许可。由印度国家研究院成员V K Paul博士领导的国家疫苗管理专家组(NEGVAC)和中央药物管制组织下属的主题专家委员会(SEC)将在未来几天审查该申请。

Sources said while the government is positive on Pfizer’s application, NEGVAC is more keen on vaccines candidates being tested in the country.

消息人士称，虽然政府对辉瑞的申请持肯定态度，但NEGVAC更热衷于正在印度测试的候选疫苗。

According to sources, the government is expecting around 40 crore doses of Covishield vaccine over five to six months.While the government will need around 60 crore doses of the two-dose vaccine to inoculate the targeted 30 crore priority population, it is likely to get adequate doses once Covaxn and Sputnik V are approved.

据消息人士透露，政府预计在5到6个月的时间内注射大约4亿剂Covishield疫苗。虽然政府需要大约6亿剂两剂疫苗为3亿优先人口接种，但一旦Covaxn和Sputnik V获得批准，剂量应该足够。

印度时报读者的评论：译者：Jessica.Wu

Shankara Rao T S

It is heartening to note that Oxford AstraZeneca Vaccine manufactured by SII has applied for permission for emergency usage - efficacy is around 70 % which is well above 50 % norm internationally accepted. This is the cheapest vaccine among vaccines and handling is easy.

令人鼓舞的是，印度血清研究所生产的牛津阿斯利康疫苗已申请紧急使用许可——有效性约为70%，远高于国际公认的50%标准。这款疫苗是所有疫苗中最便宜的。

K Mohan

Not all need the vaccine and therefore we may be self sufficient and need not go for imported ones

并非所有人都需要接种疫苗，我们可以在本土生产，自给自足，不需要进口疫苗

Mudi Ji

Lol by July? Developed countries are starting vaccination this week or latest by end of this month. Where are the bhakts calling India developed nation? Why India is at bottom of priority list on Pfizer which currently has the most promising vaccine? They are also selling first to actual developed nations.

到明年7月?发达国家将在本周或最迟在本月底开始接种疫苗。那些称印度为发达国家的人在哪里?辉瑞公司的疫苗目前最有希望的，为什么印度排在辉瑞优先供应名单的最后?他们将先销售给真正的发达国家。

SOURABH RATTA

politics is yet to start on vaccine. politicans will ask for quota system soon.

政客们很快就会要求在接种疫苗时实行配额制度。

Guest

Get a vaccine ASAP and immunise Health workers first and then Elderly and finally those with Coexsting Disease.

尽快接种疫苗，首先给卫生工作者接种，然后是老年人，最后是那些同时患有其他疾病的人。

Quhesobi

It shows again that Feku, aka Surrender Modi, has failed in each and every aspect. We will already reach "herd immunity" through natural infection by next July.

这再次表明，莫迪在各方面都失败了。到明年7月，我们都实现“群体免疫”了。

Dreet

African countries did a better job than India and America in the fight against Covid 19 and Ebola Virus.

All airports in Africa were shut down when India was busy hosting Namaste Trump

在对抗新冠和埃博拉病毒方面，非洲国家比印度和美国做得更好。

当印度忙着招待特朗普时，非洲所有机场都关闭了

Bijoy Raj Guha

Remember, An act in haste is always a waste,.....

记住，欲速则不达……

Dreet

Just Moderna and Pfizer vaccine for the common man in India. No cheap ineffective vaccines please.

为印度人接种Moderna和辉瑞的疫苗，请不要选择廉价无效的疫苗。

Shobhit K

So it is confirmed that only 30 crore people will get the vaccine in 2021. Andhbhakts are happy.What about the remaining 110 crore people who are left to die in 2021??

因此，可以确定的是，2021年只有3亿人可以接种疫苗。那剩下的10亿1千万人怎么办？等死吗?

P Narasiman

Vaccine hopes are increasing for the commonmen in India. This hopes will encourage the businesses and also our economy.

印度老百姓接种疫苗的希望越来越大。这将鼓励企业，刺激我们的经济。

Ranjit KR

As per govt indas corono cases are going down daily ,people are recovering and getting natural antibodies, vaccine is not so urgernt , yes for america and european countries daily cases going high they might need urgent vaccines ..

根据印度政府的说法，确诊病例每天都在下降，人们正在康复，获得了天然抗体，那印度就那么迫切需要疫苗了啊，美国和欧洲国家的确诊病例每天都在上升，他们可能急需疫苗。

Chetan Mukhija

let the people who can buy have it first. don't socialize all the vaccines to freebies. after all its our tax money which support state and freebies.

让有能力支付费用的人先接种疫苗，不要全部免费接种，毕竟免费疫苗也要纳税人买单。

Ravi Chandra Singu

The vaccine should available to all the citizens of India. So don't do business with the peoples health, just providing to sum group of people.

不要只给一部分人提供，要为所有印度公民提供疫苗，不要拿人们的健康做生意。

Prasenjit Das

Pfizer vaccine should be permitted. It has 95 percent efficiently and good safety profile.

辉瑞疫苗的有效性达到95%，很安全，应该批准使用。

P Narasiman

Let us hope that these Vaccines get successful in their phase 3 trials and approved by the competent authorities. Also hope that our Government keeps up the promises.

希望这些疫苗在其第三阶段试验中获得成功，并得到主管当局的批准。也希望我们的政府遵守诺言。

Trumpendra donaladodi

COvaxn indian vaccine is flop already Haryana minister. Got carona hahaha

印度本土新冠疫苗COvaxn已经是失败了，哈里亚纳邦的一个部长注射后确诊了，哈哈哈